Implanon uptake at the university of Calabar teaching hospital Calabar, Nigeria
A five year review
Keywords:
Implanon, socio-demographic profile, menstrual irregularities, CalabarAbstract
Background: Implanon is a modern hormonal contraceptive with a long-acting and reversible effect. It is effective for up to 3 years and can be given during breastfeeding, thus preventing early pregnancy in about 99% of breastfeeding mothers. The current prevalence rate for contraceptive use in Nigeria is approximately 11%–15%. This rate is very low in spite of the high rate of sexual activity and widespread awareness of the various contraceptive methods among Nigerian adolescents and youths. Objective: To determine the socio-demographic profile of implanon acceptors, the side effects profile and reasons for discontinuation of the method in Calabar. Method: This was a five-year retrospective review of records of clients who accepted Implanon at the University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria. Result: During the period under review, 311 clients accepted Implanon as a method of modern contraceptive in this tertiary facility. The mean age of users was 31.0 5.5SD. Of this number, 97.7% were Christians while 2.3% were Muslims. 93.6% of the clients had at least secondary education and above, 52.7% of the clients had three or more children at the point of accepting the method. However, 80.0% of them desired future fertility. T
Downloads
References
Etuk S. J., Ekanem A. D. Knowledge, attitude and practice of family planning amongst women with unplanned pregnancy in Calabar, Nigeria. Nigerian Journal of Physiological sciences. 2003; 18: 65 – 71
National Population Commission (NPC) and ICF macro (2009) Nigeria Demographic Health Survey 2008: Key findings. Calverton, Maryland, U.S.A: NPC & ICF macro. 11: 63 – 86
Austin A. Unmet Contraceptive need among married Nigerian women: an examination of trends and drivers. J contraception 2015 Jan; 91 (1) : 31 – 38
Canning D., Schultz T. P. The economic consequences of reproductive health and family planning. The Lancet. 2012;380: 165 – 171
Schultz T. P., Shareen J. Family planning and women’s and children’s health: consequences of an outreach program in Matlab, Bangladesh. Demography. 2013; 50 (1): 149 – 180
Okonofua F. and Odunsi K. (eds) Contemporary Obstetrics and Gynaecology for Developing Countries; 2003. WHARC, Benin City, Nigeria. 110 – 119. Association of Reproductive Health Professionals (2008). History of subdermal contraceptive implants. Association of Reproductive Health Bulletin.
Monjok E, Smesny A, Ekabua JE. Contraceptive practices in Nigeria: Literature review and recommendation for future policy decisions. Open access contraception 2010; 1: 9 – 22
Power J, French R, Cowan FM. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database of Systematic Reviews. 2007: 3.
Adekunle AO. Recent advances on Contraceptive development. In: Ojule JD, Oranu EO, Enyindah CE. Experience with implanon in Southern Nigeria. Journal of Med and Med Sciences, 2012; 3(1):710 – 14.
Balogun OR, Olaomo N, Adeniran AS, Fawole AA. Implanon subdermal implant: an emerging method of contraception in Ilorin, Nigeria. Journal of Med and Biomedical Sciences, 2014; 3(1):1 – 5
Mestad R, Secura G, Allsworth JE, Madden T, Zhau Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the contraceptive CHOICE project – Contraception 2011; 84:493 – 8.
Guazzelli CA, de Queiroz FT, Barbieri M, Torloni MR, de Araujo FF. Etornorgestrel implants in adolescents: Evaluation of clinical aspects. Contraception 2011; 83:336 – 9
Lewis LN, Doherty DA, Hickey M, Skinner SR. Implanon as a contraceptive choice for teenage mothers: A comparison of contraceptive choices, acceptability and repeat pregnancy. Contraception 2010; 81:421 – 6.
Marrone G, Abdul-Rahman L, De Coninck Z, Johansson A. Predictors of Contraceptive use among female adolescents in Ghana. Afr J Reprod Health 2014; 18:102 – 9.
Ankomah A, Anyanti J, Oladosu M. Myths, misinformation and communication about family planning and contraceptive use in Nigeria. Open Assess J Contracept 2011; 2: 95 – 105
Palamuleni ME. Socio-economic and demographic factors affecting contraceptive use in Malawi. Afr J Reprod Health 2013; 17:91 – 104
Aisien AO, Enosolease ME. Safety, efficacy and side-effects of implanon, a single rod implantable contraceptive (etornorgestrel) in University of Benin Teaching Hospital. Niger J Clin Pract. 2010; 13(3):331 – 5.
Akadri AA, Odelola OI. Progestogen – only injectible contraceptive: Acceptor prevalence and client experience at Sagamu, Nigeria. Niger Postgrad Med J 2017; 24:178 – 81
Adeyemi AS, Adekanle DA, Progestogen – only injectable contraceptive: Experience of women in Osogbo, Southwestern, Nigeria. AM Afr Med 2012; 11: 27 – 31.
Hou MM, McNicholas C, Creinin MD. Combined oral contraceptive treatment for bleeding complaints with etornorgestrel contraceptive implant: A randomized control trial. Eur J Contracept Reprod Healthcare 2016; 21:361 – 66.
Friedlander E. Therapeutic options to unscheduled vaginal bleeding associated with long-acting reversible contraception. Obstetrics and Gynaecology Clinics of North America 2015; 42: 593 – 603.
Adebola O, Imran O, Morhason – Bello, Michael A, Okuniola, Adeyemi O, Adekunle. Profile of Implanon acceptors and pattern of side effects. J Reprod Med 2015, Mar; 26(1): 46 – 52
Abeshi, Sylvester E; Eyong, Edu M; Ekenjoku, A J; Ekpo, Edet E -Current trend in contraceptive demand at the university of Calabar teaching hospital, Calabar, Nigeria. Asian journal of science and technology 11 (05); 10972-10974, 2020
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
